期刊文献+

益肾活血方对家兔血瘀模型纤溶系统作用的实验研究 被引量:3

Study on function of decoction for invigorating the kidney and improving blood circulation on rabbits blood stasis model
下载PDF
导出
摘要 目的 :探讨益肾活血药对家兔血瘀模型纤溶系统的作用。方法 :兔 30只 ,随机分为健康组、模型组、益肾活血方大剂量组和小剂量组、血栓宁组 ,各组相应处理后分别取静脉血检测组织型纤溶酶原激活剂 (t PA)、纤溶酶原激活剂抑制物 (PAI)、纤维蛋白原 (Fbg)、D 二聚体 (DD)。每组随机取一只内脏作病理检查。结果 :t PA ,PAI,Fbg,DD ,健康组与模型组比P <0 .0 1,大、小剂量组、血栓宁组与模型组比P <0 .0 5 ,大、小剂量组与血栓宁组比P <0 .0 5 ,大剂量组与小剂量组比P >0 .0 5。病理改变模型组较重 ,血栓宁组次之 ,大、小剂量组较轻 ,健康组无异常变化。结论 :造模成功 ,大、小剂量组及血栓宁组对血瘀模型纤溶系统均有作用 ;大、小剂量组强于血栓宁组。病理改变符合血液检测变化。 Objective: To evaluate the effect of decoction for invigorating the kidney and improving blood circulation to thrombosis on rabbits blood stasis model. Method: Thirty rabbits were ramdomly divided into normal group, model group, heavy dose group, slight dose group and Xue Shuan Ning group. Tissue-typ eplasminogen activator (t-PA), plasminogen activator inhibitor (PAI), fibrinogen (Fbg) and D-dimer (DD) were investigated after those rabbits had been treated. One was selected randomly from each group to observe pathological changes. Result: There was significant difference in t-PA, PAI, Fbg and DD between normal group and other groups ( P <0.01). Among groups of heavy dose, slight dose, Xue Shuan Ning and model, the statistical differences were significant, as well as among groups of heavy dose, slight dose and Xue Shuan Ning ( P <0.05). However,there was no statistical difference between heavy dose group and slight dose group ( P >0.05). The pathological changes in model group were most serious, and those in Xue Shuan Ning were less serious. There were slight pathological change in heavy dose group and light dose group. Conclusion: Models were made successfully. Heavy dose group and slight dose group have stronger effect on thrombosis than Xue Shuan Ning group.
出处 《中国中药杂志》 CAS CSCD 北大核心 2004年第5期440-443,共4页 China Journal of Chinese Materia Medica
基金 浙江省中医管理局立项课题 (960 3 6)
关键词 益肾活血方 家兔 血瘀模型 纤溶系统 身体健康 invigorating the kidney and improving blood circulation blood stasis model thrombosis pathology
  • 相关文献

参考文献8

二级参考文献10

  • 1夏豪,李庚山,许家璃,蒋锡嘉.三七总皂甙对兔颈动脉内皮剥脱术后c-myc基因表达及血管平滑肌增殖的影响[J].中国介入心脏病学杂志,1997,5(1):45-47. 被引量:21
  • 2Ishiwata S,Tukada T,Nakanishi S,et al.Postangioplasty restenosis:phtedet activation and the coagulation-fibtinolysis system as possible factors in the pathogenesis of restenosis [J]. Am Heart J,1997;133(4):387.
  • 3Yu JC, Lokkcr N A, Hollcnbach S, et al. Efficacy of the noval selective phtelet-dcrivcd growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury[J].J Phannacol Exp Ther,2001;298:1172.
  • 4Yamasaki Y, Miyoshi K, Oda N, et al. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis [J ]. Circulation tkesearch, 2001;88:630.
  • 5Christen P, Vetin V, Bochaton PML, et al. Mechanisms of neointima formation and remodeling in the porcine coronary[J].Circulation, 2001; 103: 882.
  • 61,Zalewski A, etal. Evidence for reduced fibrinolytic activity in unstable angina at rest: clinicalbiochemical and angiographic correlates. Circulation, 1991,83:1685.
  • 72,Almer LO, Ohlin H. Elevated levels of the rapid inhibitor of plasminogen activator(t-PA) in acute myocardial infarction. Thromb Res, 1987,47:335.
  • 83,Gram J, et al. Depression of tissue plasminogen activator (t-PA) activity and rise oft-PA inhibition and acute phase reactants in blood of patients with acute myocardialinfarction (AMI). Thromb Haemost, 1987,58:817.
  • 94,Hoffmeister Hu, Jur U, Wendel HP, et al. Alterations of coagulation and fibrinolyticand kallikrein-kinin systems in the acute and post-acute phase in patients with unstableangina pectoris. Circulation, 1995,91:2520.
  • 105,Toss H, Lindahl B, Siesbahn A, et al. Prognostic influence of increased fibronogen andC-reactive protein levels in unstable coronary artery disease. Circulation,1997,96:4204-4221. (1999-12-27) (本文编辑:顼志敏)

共引文献20

同被引文献20

  • 1杨国辉,朱春玲,周志邦,罗殿熙,唐筑灵,张小蕾.肾脏病患者血浆过氧化脂质含量和血清超氧化物歧化酶含量的观察[J].贵州医药,1995,19(2):90-91. 被引量:3
  • 2赵虹.中药治疗多囊卵巢综合征的药物机制研究[J].中国中医药科技,2007,14(1):62-64. 被引量:6
  • 3陈奇 邓闻龙.中药药理研究方法学[M].北京:人民卫生出版社,1996.494-499.
  • 4赵荣瑞.血液流变学与心血管活动[J].生理科学进展,1986,(2):177-177.
  • 5Poretsky L,Clemons J,Bogovich K.Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats.Metabolism.1992;41(8):903
  • 6尤昭玲 冯光荣.多囊卵巢动物模型构建的探索[J].中华现代中西医杂志,2004,2(11):964-964.
  • 7Diamanti-Kandarakis E,Palioniko G,Alexandrakr K,et al M.The prevalence of4G5G polymorphism of plasminogen activator inhibitor-1(PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.Eur J Endocrinol,2004; 150(6):793
  • 8Beer WH.Follicular plasminogen and plasminogen activor and the effect of plasmin on ovarian follice wall.Cell,1995;6:379
  • 9Atiomo WU,Bates SA,Condon JE,et al,Fertil Steril,1998;69(2):236
  • 10Tarkun 1,Canturk Z,Arslan BC,et al.The plasminogen activator system in young and lean women with polycysitic ovary syndrome.Endocr J,2004;51(5):467

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部